CRA was retained by the plaintiff in a patent dispute to determine the amount of reasonable royalties due as a result of infringement of a patent by a major medical device company. CRA’s intellectual property expert evaluated the economic and technological comparability of multiple license agreements, the feasibility of non-infringing alternatives, and the Georgia-Pacific factors to determine the appropriate reasonable royalty rate. Dr. Sean Sheridan submitted an expert report and provided testimony in deposition. The case settled prior to trial.
CRA consultants named top patent professionals in the 2025 IAM Patent 1000 rankings
Fourteen CRA consultants were recognized as leading economic, financial, and licensing expert witnesses by Intellectual Asset Management (IAM). The IAM Patent...